O S Levin, I A Voznyuk, S N Illarioshkin, O N Tkacheva, A N Bogolepova, E E Vasenina, S I Gavrilova, T V Dokukina, A Y Emelin, V Y Lobzin, E A Mkhitaryan, S E Khatkova, M A Yakushin, S N Yanishevskiy
The aging of the population and the associated increase in the share of cognitive impairments in the structure of a wide range of diseases are a serious challenge for modern healthcare. Difficulties in the treatment of cognitive disorders are determined by many factors, including the age of patients, comorbidity, forced polypragmasia and the adequacy of the dosage of drugs that restore cognitive activity. The experts discussed information about the therapeutic potential of the drug Cerebrolysin in the treatment of cognitive disorders of various origins, stated significant experience of its effective and safe use in many clinical studies in mild and moderate forms of dementia...
2023: Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova